For more information or confidential assistance
se habla español

Monitoring, Dosing Adjustments could Minimize Pradaxa Bleeding Events, Investigation Finds

An investigation by Deborah Cohen of the British Medical Journal (BMJ) has revealed that Pradaxa manufacturer Boehringer Ingelheim may have withheld analyses that might have prevented some Pradaxa bleeding events. Monitoring and dosing adjustments could make use of the drug even safer and more effective, according to Cohen’s findings. However, the... Read more »